SUBSCRIBE
SUBSCRIBE
Pharm Country

Progenics Pharmaceuticals, Inc. to Participate in Investor Conferences

March 30, 2012 | 
1 min read

TARRYTOWN, N.Y., March 29, 2012 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) chief executive officer Mark R. Baker will present at two upcoming investor conferences in New York City:

Events
MORE ON THIS TOPIC
Note paper with blood donation concept on red background
Sickle cell disease
Vertex, Beam Report SCD Cell and Gene Therapies Advances at ASH 2024
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Bladder cancer
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Cancer
AstraZeneca/Daiichi Sankyo, BioNTech, Merus to Present Promising Cancer Therapies at ESMO Asia 2024
December 2, 2024
 · 
4 min read
 · 
Tristan Manalac
Human liver protection. Wireframe low poly style. Concept for medical, pharmacology, treatment of the hepatitis. Abstract modern 3d vector illustration on dark blue background.
MASH
Novo, Viking Heat Up MASH Space with Promising Data at AASLD24
November 20, 2024
 · 
3 min read
 · 
Tristan Manalac